Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
Sirius XM Q3 Earnings: Net Income Hit by $3.4 Billion Liberty Impairment Charge, Revises Annual Outlook By 1%
October 31, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
From Benzinga
From Benzinga
STMicroelectronics' Q3 Results Highlight Weak Automotive Demand, Gross Margin Squeeze: Details
October 31, 2024
From Benzinga
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
October 31, 2024
From Benzinga
Mastercard Q3 Earnings: Revenue And EPS Beat, Cross Border Transactions Growth, Sees European Consumer Confidence Improvement
October 31, 2024
From Benzinga
Ambev Q3 Sales Miss Expectations As Volume Growth Stalls; Shares Dip
October 31, 2024
From Benzinga
SolarWinds Q3 Earnings: Subscription Gains Drive Revenue, Raises Full-Year Forecast
October 31, 2024
From Benzinga
Altria Q3: Earnings Beat, NJOY Gains Ground, But Marlboro Loses Share In Shrinking Market
October 31, 2024
From Benzinga
TotalEnergies Boasts Strong Revenue Despite Q3 EPS Miss, Decline In LNG And Production
October 31, 2024
From Benzinga
Cheez It Parent Kellanova's Q3 Earnings: Organic Sales Climb, Mars Buyout Vote Nears & More
October 31, 2024
From Benzinga
From Benzinga
Peloton Gears Up For Next Chapter: Sales Beat, Apple Alum As CEO, And Strong Margin Gains
October 31, 2024
From Benzinga
Parker-Hannifin Reports Q1 Results, Sees Mixed Outlook With Industrial Pressure But Aerospace Gains
October 31, 2024
From Benzinga
Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients
October 31, 2024
From Benzinga
Hyatt's Earnings Miss Clouds Q3, Eyes Strong 2024 With Bold Pipeline And Expanding Member Base
October 31, 2024
From Benzinga
Anheuser-Busch Q3 Beats, But Beer Volume Drops Globally
October 31, 2024
From Benzinga
Southern Company Q3: Revenue Misses, But EPS Beats Expectations with Strong Utility Gains
October 31, 2024
From Benzinga
Merck Beats Q3 Estimates, But Lowers Annual Forecast As Gardasil Vaccine Hit By Low China Demand
October 31, 2024
From Benzinga
From Benzinga
From Benzinga
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
From Benzinga
Roblox Q3 Earnings: Bookings Jump 34%, User Base Hits 89 Million, Raises Annual Outlook
October 31, 2024
From Benzinga
From Benzinga
Estée Lauder Q1 Earnings: China Uncertainty Hits Beauty Giant, Withdraws FY25 Outlook, Stock Tanks
October 31, 2024
From Benzinga
Comcast Q3 Earnings: Olympics Power NBCUniversal Gains, Peacock Hits 36M Subscribers, Explores Forming New Company Of Cable Networks
October 31, 2024
From Benzinga
From Benzinga
Mobileye Q3 Earnings: Revenue And EPS Beat, $2.7 Billion Impairment Hit, CEO Outlines Strategic Goals
October 31, 2024
From Benzinga
What's Going On With Taiwan Semiconductor Stock On Thursday?
October 31, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
